Poppi
acquired by PepsiCo for nearly $2 billion, explicitly to accelerate PepsiCo's "Positive Choices" growth strategy and functional food and beverage offerings.
- Country
- United States
Coverage
| EU | IN | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsfda
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bio-nutraceutical drinks and functional beverages | food-alt-protein | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.